Abstract

The present invention relates to compositions comprising lutein, non-digestible carbohydrates and at least one of casein phosphopetides or 1,3-dioleoyl-2-palmitoylglycerol.

IPC Classes  ?

• A61K 31/047 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/18 - PeptidesProtein hydrolysates
• A61K 31/231 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]

Abstract

The invention relates to a synbiotic composition comprising Bifidobacterium ssp., non- digestible oligosaccharides, and pectin polysaccharides having a molecular weight between 50-2000 kDa, the backbone thereof comprising at least 55% by weight of the polysaccharide of 1,4-linked a-D-galacturonic acid residues and having a degree of methylation (DM) of at least 35% and/or a pectin polysaccharide that has a degree of polymerisation of at least 260. The invention further relates to a nutritional composition comprising the synbiotic composition. The invention further relates to the use of the synbiotic composition for treating or preventing gut dysbiosis, preferably antibiotic-induced gut dysbiosis.

IPC Classes  ?

• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 31/733 - Fructosans, e.g. inulin

Abstract

A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.

IPC Classes  ?

• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 51/20 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing
• B65D 53/02 - Collars or rings
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers
• B65D 81/20 - Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas

Abstract

A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.

IPC Classes  ?

• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 3/22 - Rigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with double wallsRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls incorporating air-chambersRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls made of laminated material
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 51/22 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing having means for piercing, cutting, or tearing the inner closure
• B65D 53/02 - Collars or rings
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers
• B65D 81/20 - Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
• B65D 81/30 - Adaptations for preventing deterioration or decay of contentsApplications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation

Abstract

The present invention concerns a composition comprising dietary fiber for use in the dietary management of methylmalonic acidemia (MMA) and/or propionic acidemia (PA), and/or for use in treating and/or reducing MMA and/or PA, and/or treating, reducing and/or preventing symptoms associated therewith.

IPC Classes  ?

• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/155 - Vitamins A or D
• A23L 33/16 - Inorganic salts, minerals or trace elements
• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/22 - Comminuted fibrous parts of plants, e.g. bagasse or pulp
• A23L 33/24 - Cellulose or derivatives thereof
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
• A61K 31/717 - Celluloses
• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61K 31/733 - Fructosans, e.g. inulin
• A61K 31/736 - Glucomannans or galactomannans, e.g locust bean gum, guar gum
• A61K 33/06 - Aluminium, calcium or magnesiumCompounds thereof
• A61K 35/745 - Bifidobacteria
• A61K 35/747 - Lactobacilli, e.g. L. acidophilus or L. brevis
• A61P 7/08 - Plasma substitutesPerfusion solutionsDialytics or haemodialyticsDrugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Abstract

A nutritional composition comprising sn-2 palmitic acid and A2 beta-casein for use in improving the gut microbiota in a human subject.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23D 9/00 - Other edible oils or fats, e.g. shortenings or cooking oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/19 - Dairy proteins

Abstract

A nutritional composition comprising sn-2 palmitic acid and lactoferrin for use in improving the gut microbiota in a human subject.

IPC Classes  ?

• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 35/00 - Medicinal preparations containing materials or reaction products thereof with undetermined constitution
• A61K 35/745 - Bifidobacteria
• A61K 35/747 - Lactobacilli, e.g. L. acidophilus or L. brevis
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• A61K 38/40 - Transferrins, e.g. lactoferrins, ovotransferrins
• A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
• A61P 31/04 - Antibacterial agents

Abstract

The invention provides a computer implemented method of analysing at least one excreta, comprising the steps of; - receiving a first visual information of a first excreta of a first subject; identifying at least one region of interest within the first visual information; - applying a trained machine learning model to the identified at least one region of interest in order to identify characteristics of the first excreta; and determining a microbiome profile of the first excreta based on the identified characteristics of the first excreta, wherein said characteristics comprise at least one of colour, consistency, and texture. The invention further provides a non-transitory computer readable medium and a system for analysing at least one excreta.

IPC Classes  ?

• G16H 30/40 - ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
• C12Q 1/04 - Determining presence or kind of microorganismUse of selective media for testing antibiotics or bacteriocidesCompositions containing a chemical indicator therefor
• G06T 7/00 - Image analysis
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• A61B 10/00 - Instruments for taking body samples for diagnostic purposesOther methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determinationThroat striking implements
• G01N 33/493 - Physical analysis of biological material of liquid biological material urine
• G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
• G06V 10/54 - Extraction of image or video features relating to texture
• G06V 10/56 - Extraction of image or video features relating to colour

Abstract

A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.

IPC Classes  ?

• G06T 7/00 - Image analysis

Abstract

A process of preparing a shelf-stable liquid enteral nutritional composition, said process comprising the steps of providing an oil-in-water emulsion, sterilizing the emulsion by direct steam injection (DSI) to obtain a sterilized emulsion with a F0 value of at least 3 and subjecting the sterilized emulsion to high pressure homogenization.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23C 9/152 - Milk preparationsMilk powder or milk powder preparations containing additives
• A23J 1/20 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from milk, e.g. caseinObtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from whey
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

Abstract

The invention pertains to a fiber mixture comprising arabinoxylan, beta-glucan, pectin, and resistant starch, nutritional compositions comprising the fiber mixture and uses thereof. The fiber mixture comprising is beneficially used in improving intestinal health and/or preventing impaired intestinal health.

IPC Classes  ?

• A61K 31/717 - Celluloses
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/716 - Glucans
• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61K 31/732 - Pectin
• A61K 36/899 - Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
• A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

The invention relates to a particulate nutritional composition for infants with less powder segregation, wherein the particulate nutritional composition comprises milk formula particles and probiotic particles, which differ in particle size. The invention further relates to a process for producing the particulate nutritional composition and to a use of the particulate nutritional composition.

IPC Classes  ?

• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
• A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs

Abstract

The present invention lies on the field of synergistic compositions for improving mineral bioaccessibility, in particular iron and/or calcium bioaccessibility. The synergistic compositions comprise lutein, casein phosphopeptide or 1,3-dioleoyl-2-palmitoylglycerol, preferably in combination with a non-digestible carbohydrate. The invention further relates to the use of the compositions in preventing and/or treating mineral deficiency and associated conditions, preferably anaemia.

IPC Classes  ?

• A61K 31/047 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
• A61K 31/231 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 33/06 - Aluminium, calcium or magnesiumCompounds thereof
• A61K 33/26 - IronCompounds thereof
• A61K 33/30 - ZincCompounds thereof
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• A61P 3/02 - Nutrients, e.g. vitamins, minerals

Abstract

The present invention relates to nutritional compositions comprising lutein for inhibiting mast cell degranulation, thereby preventing or treating symptoms or disorders associated with mast cell degranulation. Preferably, the compositions comprise lutein and non-digestible carbohydrates, such as those selected from prebiotic oligosaccharides, human oligosaccharides and combinations thereof.

IPC Classes  ?

• A61K 31/047 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/231 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans

Abstract

The present invention relates to the combination of lutein and 1,3-dioleoyl-2-palmitoylglycerol.

IPC Classes  ?

• A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
• A61K 31/045 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates
• A23L 33/12 - Fatty acids or derivatives thereof
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
• A61P 1/12 - Antidiarrhoeals
• A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
• A61P 3/00 - Drugs for disorders of the metabolism

Abstract

The present invention relates to compositions comprising lutein and 1, 3-dioleoyl-2-palmitoylglycerol.

IPC Classes  ?

• A61K 31/045 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates
• A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
• A61P 1/12 - Antidiarrhoeals
• A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
• A61P 3/00 - Drugs for disorders of the metabolism

Abstract

The present invention relates to an oat base with improved health-beneficial properties. The invention also provides for uses of the oat base or a composition comprising the oat base for increasing intestinal short chain fatty acid and/or L-lactate production and/or reducing intestinal gas production and/or modulating the gut microbiota in a subject, as well as health benefits associated with increased intestinal acetate and/or L-lactate production.

IPC Classes  ?

• A23C 11/10 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
• A23L 7/10 - Cereal-derived products
• A61P 3/04 - AnorexiantsAntiobesity agents
• A61P 9/00 - Drugs for disorders of the cardiovascular system

Abstract

The present invention relates to a liquid cereal base. The invention also provides a method for obtaining the liquid cereal base and uses thereof as ingredient of plant-based food and beverage products.

IPC Classes  ?

• A23C 11/10 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
• A23L 7/10 - Cereal-derived products

Goods & Services

Computer program (downloadable software); computer software, recorded; computer software applications, downloadable; downloadable mobile applications Educational services; providing educational information; provide online educational information; arranging and conducting of in-person educational forums; arranging and conducting of educational conferences; instruction of body therapy; beauty training; medical training and teaching; arranging and conducting of workshops [training]; instruction services Scientific research and development; scientific research; research in the field of food; medical research; technical advice related to research on food and dietary supplements; technical consultation related to technical research in diet; research and development of new products; research and development of new products for others; development of pharmaceutical preparations and pharmaceuticals; genetic screening [for scientific purposes]; biological research; biological research and analysis; structural and functional analysis of genomes; biomedical research Health care; medical information; nutrition advisory service; nutrition consultation; medical consultations; medical services; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Abstract

The invention pertains to a substantially gluten-free ketogenic flour blend having a ketogenic weight ratio between 2.3:1 and 2.9:1, preferably between 2.4:1 and 2.9:1, the blend comprising between 50 and 70 gram lipid per 100 g dry weight, comprising at least one, more preferably at least two, most preferably all of: (a) between 15 and 20 g MCT/100 g dry weight; (b) MCT providing 20 – 30% of the total energy content of the blend; (c) between 20 and 35 wt% MCT based on total weight of the lipid, and further comprising at least 2.5 g/100 g dry weight of fructo-oligosaccharides (FOS) and/or galacto- oligosaccharides (GOS), preferably FOS.

IPC Classes  ?

• A21D 2/16 - Fatty acid esters
• A21D 2/18 - Carbohydrates
• A21D 2/26 - Proteins
• A21D 2/36 - Vegetable material
• A21D 13/06 - Products with modified nutritive value, e.g. with modified starch content
• A21D 13/066 - Gluten-free products
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A21D 13/80 - Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
• A61P 25/08 - AntiepilepticsAnticonvulsants
• A61P 25/16 - Anti-Parkinson drugs
• A61P 25/18 - Antipsychotics, i.e. neurolepticsDrugs for mania or schizophrenia
• A61P 25/22 - Anxiolytics
• A61P 25/24 - Antidepressants
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The invention pertains to a synthetic mixture of human milk oligosaccharides (HMOs) wherein the mixture comprises 10 – 30 wt% acidic HMOs and 70 – 90 wt% neutral HMOs, wherein the neutral HMOs comprises 75 – 95 wt% of fucosylated HMOs based on weight of the neutral HMOs and wherein the mixture comprises at least 19 HMOs.

IPC Classes  ?

• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Abstract

The invention pertains to a synthetic mixture of human milk oligosaccharides (HMOs) comprising 10 – 30 wt% acidic HMOs and 70 – 90 wt% neutral HMOs, wherein the neutral HMOs comprises 75 – 95 wt% of fucosylated HMOs based on weight of the neutral HMOs, and use of the mixture of HMOs in the treatment and/or prevention of infections.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Goods & Services

(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings

Abstract

The invention relates to nutritional compositions comprising a mixture of non-digestible oligosaccharides comprising short-chain fructo-oligosaccharides, long-chain fructo-oligosaccharides and 2'-fucosyllactose that have been shown to provide a beneficial short-chain fatty acids profile and intestinal bifidobacteria population. The nutritional compositions are for infants and young children and are in particular beneficial for infants or young children suffering from food allergy, in particular cow's milk protein allergy.

IPC Classes  ?

• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters

Goods & Services

(Based on 44(e))(Based on Intent to Use) Cereals, processed; Cereals prepared for human consumption; Breakfast cereals; Processed cereal-based food to be used as a breakfast food, snack food or ingredient for making other foods; Cereal bars; Cereal-based snack foods; High-protein cereal bars; Cereal based energy bars (Based on Intent to Use) Muesli; Rice-based snack foods; Biscuits; Cakes; Pastries; Sugar; Confectionery made of sugar; Candy; Dessert mousses; Pancakes; Waffles; Chocolate; Cocoa-based beverages; Chocolate-based beverages containing milk; Chocolate-based drinks; Coffee-based beverages; Tea-based beverages; Custard; Ice cream; Edible ices; Fruit coulis; Chocolate-based spreads; Chocolate-based spreads also containing nuts; Sherbets; Confectionery ices

Abstract

The invention relates to an emulsified O/W composition comprising emulsified lipid and OSA starch wherein the dry weight ratio of OSA starch to lipid is in the range from 1:3 to 1:5 and wherein less than 4 wt% protein is present based on total dry weight of the emulsified O/W composition and relates to the nutritional composition comprising the emulsified O/W composition and to the method of making these compositions and further relates to a nutritional composition for use in glycogen storage disease.

IPC Classes  ?

• A23L 29/212 - StarchModified starchStarch derivatives, e.g. esters or ethers
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 35/00 - Foods or foodstuffs not provided for in groups Preparation or treatment thereof
• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

The invention relates a nutritional compositions comprising lipid, OSA starch, protein, an encapsulating agent and carbohydrates, wherein the composition comprises lipid-containing particles which have a lipid core and wherein said lipid core is coated with OSA starch, and wherein the lipid core and OSA starch coating comprise less than 4 wt% protein altogether and relates to the method of making the nutritional compositions and further relates to the nutritional composition for use in glycogen storage disease.

IPC Classes  ?

• A23L 29/212 - StarchModified starchStarch derivatives, e.g. esters or ethers
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 35/00 - Foods or foodstuffs not provided for in groups Preparation or treatment thereof
• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

The invention pertains to nutritional compositions and uses thereof comprising digestible carbohydrates, lipids, protein, 3-fucosyllactose (3-FL) and a source of butyrate suitable for providing nutrition to an infant or young child suffering from or at risk of developing a food allergy, preferably cow's milk protein or hen's egg allergy, wherein the protein is or essentially consists of hydrolysed protein and/or free amino acids and wherein the butyrate is provided in the form of dietary butyrate and/or by non-digestible saccharides selected non-digestible polysaccharides, non-digestible oligosaccharides or mixtures thereof capable of undergoing microbial fermentation in the gastrointestinal tract to produce butyrate.

IPC Classes  ?

• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/19 - Dairy proteins
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Goods & Services

Milk; Milk products excluding ice cream, ice milk and frozen yogurt; Yogurt; Milk substitutes; Plant-based milk substitutes; Cottage cheese; Milk beverages with high milk content; Compotes; Fruit-based snack food; Nut-based snack bars; Seed-based snack bars; Organic nut and seed-based snack bars; Powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry or vegetables; Meat, fish, poultry and game, not live; Meat, fish, fruit and vegetable preserves; Yogurt-based snack foods; Fruit purees Food supplements; Wheat-free and gluten-free food for the treatment of special medical and health conditions; Dietetic foods adapted for medical purposes; Food for babies; Dietetic foods and beverages adapted for medical use; Infant formula; Liquid formula milk for infants; Powdered milk for babies; Dietetic foods, namely, plant-based milk substitutes adapted for medical use; Dietetic foods, namely, non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits adapted for medical use; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; Nutritionally fortified beverages for medical purposes; Nutritional supplements; Vitamin and mineral supplements for mixing with cereals for infants; Vitamin preparations; Dietetic foods, namely, foods and beverages for pregnant, lactating and breast feeding women adapted for medical use; Dietetic foods, namely, milk for pregnant, lactating and breast feeding women adapted for medical use; Dietary fiber to aid digestion; Protein dietary supplements; Soy protein dietary supplements; Protein supplement shakes; Nutritional supplement energy bars; Natural dietary supplements; Probiotic preparations for medical use; Delivery agents in the form of food for babies with special nutritional needs that facilitate the delivery of nutritional supplements; Delivery agents in the form of milk for babies with special nutritional needs that facilitate the delivery of nutritional supplements

Goods & Services

Milk; Milk products excluding ice cream, ice milk and frozen yogurt; Yogurt; Milk substitutes; Plant-based milk substitutes; Cottage cheese; Milk beverages with high milk content; Compotes; Fruit-based snack food; Nut-based snack bars; Seed-based snack bars; Organic nut and seed-based snack bars; Powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry or vegetables; Meat, fish, poultry and game, not live; Meat, fish, fruit and vegetable preserves; Yogurt-based snack foods; Fruit purees Food supplements; Wheat-free and gluten-free food for the treatment of special medical and health conditions; Dietetic foods adapted for medical purposes; Food for babies; Dietetic foods and beverages adapted for medical use; Infant formula; Liquid formula milk for infants; Powdered milk for babies; Dietetic foods, namely, plant-based milk substitutes adapted for medical use; Dietetic foods, namely, non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits adapted for medical use; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; Nutritionally fortified beverages for medical purposes; Nutritional supplements; Vitamin and mineral supplements for mixing with cereals for infants; Vitamin preparations; Dietetic foods, namely, foods and beverages for pregnant, lactating and breast feeding women adapted for medical use; Dietetic foods, namely, milk for pregnant, lactating and breast feeding women adapted for medical use; Dietary fiber to aid digestion; Protein dietary supplements; Soy protein dietary supplements; Protein supplement shakes; Nutritional supplement energy bars; Natural dietary supplements; Probiotic preparations for medical use; Delivery agents in the form of food for babies with special nutritional needs that facilitate the delivery of nutritional supplements; Delivery agents in the form of milk for babies with special nutritional needs that facilitate the delivery of nutritional supplements

Abstract

The invention pertains to a composition for use in increasing the relative abundance of Bacteroides and Parabacteroides in the intestinal microbiota of an infant that was delivered by Caesarean section or of an infant that was exposed to antibiotics early in life (e.g. intrapartum antibiotic prophylaxis (IAP)), preferably an infant that was delivered by Caesarean section, wherein the composition comprises Bifidobacterium breve and non-digestible oligosaccharide(s).

IPC Classes  ?

• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

Abstract

The present invention relates to a process of producing a demineralised vitamin-reduced lactose concentrate, said process comprising the step of contacting a partially demineralised aqueous lactose isolate with an ion-exchange resin. The present invention further relates to a demineralised vitamin-reduced lactose concentrate.

IPC Classes  ?

• A23C 9/14 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
• A23C 9/142 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
• C13K 5/00 - Lactose
• A23L 33/15 - Vitamins
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof

Goods & Services

(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings (2) Milk and milk products ; yogurt ; milk substitutes ; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese ; milk beverages, milk predominating; compotes ; fruit-based snack foods ; nut-based snack bars ; seed-based snack bars ; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees

Goods & Services

(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings (2) Milk and milk products ; yogurt ; milk substitutes ; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese ; milk beverages, milk predominating; compotes ; fruit-based snack foods ; nut-based snack bars ; seed-based snack bars ; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees

Abstract

A method performed by an electronic device assessing weight of an infant, obtaining visual information including the infant; obtaining basic information of the infant; determining size information of the infant based on the visual information, the size information comprising at least one of length information of the infant, face information of the infant, pose information of the infant, body shape information of the infant, and chubbiness information of the infant; determining the weight of the infant based on the size information and the basic information.

IPC Classes  ?

• A61B 5/107 - Measuring physical dimensions, e.g. size of the entire body or parts thereof
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment

Abstract

A card based container has a tubular sidewall of laminate material and first and second end closures, sealed to the tubular sidewall to form a hermetically sealed package. The sidewall has an outer card layer, an inner hygienic layer and one or more sealing strips provided at an inner surface of the inner hygienic layer, located at connection locations where the sidewall seals to itself or to the respective end closures. The sealing strips include a heat-sealable polymer. The overall amount of non-paper content in the sidewall and in the package may thus be reduced.

IPC Classes  ?

• B65D 53/00 - Sealing or packing elementsSealings formed by liquid or plastic material
• B65D 5/12 - Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper by folding or erecting a single blank to form a tubular body with or without subsequent folding operations, or the addition of separate elements, to close the ends of the body with end closures formed separately from tubular body
• B65D 5/56 - Linings or internal coatings

Abstract

Provided herein is a nutritional composition having therapeutically effective amounts of a combination of (a) hydrolysed whey protein and (b) MCT for use in (i) reducing tumor growth and/or (ii) for use in improving treatment efficacy in a subject having cancer and undergoing cancer treatment.

IPC Classes  ?

• A61K 35/20 - MilkWheyColostrum
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61P 35/00 - Antineoplastic agents

Abstract

The invention relates to a first composition providing at least one of acetic acid or butyric acid for controlling ketosis associated with a ketogenic diet in a subject adhering to a ketogenic diet, wherein controlling ketosis involves a) administering the first composition, b) optionally administering a second composition comprising propionic acid to reduce ketone production/administering a second composition comprising propionic acid provided that blood ketone levels are above 3 mmol/L.

IPC Classes  ?

• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
• A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 47/38 - CelluloseDerivatives thereof
• A61P 3/00 - Drugs for disorders of the metabolism

Abstract

The invention relates to at least one of C4 or C6 fatty acids and optionally C2 fatty acids for enhancing ketosis associated with a ketogenic diet and/or preventing and/or treating resistance to a ketogenic diet, in a subject adhering to a ketogenic diet, wherein the at least one of C4 or C6 fatty acids and optionally C2 fatty acids are comprised in a non-ketogenic ketogenic diet-booster composition, or the at least C4 or C6 fatty acids and optionally C2 fatty acids are provided in non-ketogenic amounts by a dietary fibre blend comprised in a non-ketogenic ketogenic diet-booster composition.

IPC Classes  ?

• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/15 - Vitamins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

Abstract

The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant, The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant, determining a predicted age of the infant based on the at least one microbial biomarker, The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant, determining a predicted age of the infant based on the at least one microbial biomarker, wherein The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant, determining a predicted age of the infant based on the at least one microbial biomarker, wherein the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages, The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant, determining a predicted age of the infant based on the at least one microbial biomarker, wherein the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages, the predicted age is obtained based on an evaluation of the at least one measured microbial biomarker using a function based on a plurality of corresponding at least one biomarkers measured in the faecal samples from the plurality of vaginally-born breast-fed infants at the plurality of ages.

IPC Classes  ?

• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
• G16B 25/10 - Gene or protein expression profilingExpression-ratio estimation or normalisation

Abstract

The invention relates to nutritional compositions for infants and in particular formulae for infants comprising human milk oligosaccharides, specific bifidobacteria, and urea as non-protein nitrogen source for improving the intestinal microbiota.

IPC Classes  ?

• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 35/745 - Bifidobacteria
• A61P 1/12 - Antidiarrhoeals

Abstract

The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 and one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate for use in the treatment of neurodegenerative diseases and/or neurotrauma, brain injury and/or brain damage. The invention also relates to a composition comprising a combination of DHA, vitamin B2, vitamin D3 with one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate.

IPC Classes  ?

• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/15 - Vitamins
• A23L 33/155 - Vitamins A or D
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
• A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
• A61K 31/714 - Cobalamins, e.g. cyanocobalamin, vitamin B12
• A61P 25/00 - Drugs for disorders of the nervous system
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• A61L 33/00 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of bloodMaterials for such treatment

Abstract

The present invention relates to a fermented infant or follow on formula comprising non digestible oligosaccharides for decreasing duration of crying, reducing crying episodes, and incidence of colics in infants.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

Abstract

The invention relates to a neuroprotective composition comprising therapeutically effective amounts of a combination of pyruvate and citrate, for the treatment and/or prevention of neuronal damage in a subject suffering from or at risk of seizures.

IPC Classes  ?

• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
• A61P 25/00 - Drugs for disorders of the nervous system

Abstract

The invention provides a method of analysing the consistency of stool, including the steps of: providing stool of an infant, capturing, with a portable device comprising a camera, an image of the stool, providing the captured image to an input layer of a pre-trained convolutional neural network, CNN, processing the captured image using the CNN to obtain, from a final layer of the CNN, a classification vector and to obtain information about a predicted score from the classification vector, wherein at least the final layer of the CNN has been customized so that each element of the classification vector corresponds to a score of a stool analysis scale, and storing information about the predicted store.

IPC Classes  ?

• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• G06T 7/00 - Image analysis
• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment

Abstract

The invention pertains to a method for increasing and/or improving detoxification capacity comprising increasing AhR activity and/or increasing expression of CYP1A1 in a human subject comprising administering a combination of indole lactic acid (ILA) and imidazole lactic acid (IML), therapeutically effective combinations of ILA and IML for use in improving detoxification and a nutritional composition that comprises ILA and IML for use in improving detoxification.

IPC Classes  ?

• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 35/745 - Bifidobacteria

Abstract

The present invention relates to a nutritional composition for infants and young children comprising a digestible carbohydrate component, wherein the digestible carbohydrate component comprises a mixture of free galactose and at least one digestible carbohydrate selected from the group consisting of maltodextrin and glucose syrup, and with reduced or no lactose and glucose. The invention also relates to the use of the nutritional composition according to the invention for improving body composition or body composition development.

IPC Classes  ?

• A23C 9/20 - Dietetic milk products not covered by groups
• A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61P 3/04 - AnorexiantsAntiobesity agents
• A61P 37/00 - Drugs for immunological or allergic disorders

Abstract

The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 – 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated MPC, MPI or MCI obtainable by the process of the invention, and to a liquid heat- sterilized enteral nutritional composition comprising 2.0 – 3.0 kcal/ml wherein 16 – 35 en% is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 – 18 g/100 ml protein, preferably 12 – 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 – 80 mg/100kcal, preferably at least 30 – 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 – 80 mg/100kcal.

IPC Classes  ?

• A23C 7/04 - Removing unwanted substances from milk
• A23C 9/15 - Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
• A23J 1/20 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from milk, e.g. caseinObtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from whey
• A23J 3/10 - Casein
• A23J 3/32 - Working-up of proteins for foodstuffs by hydrolysis using chemical agents
• A23L 33/19 - Dairy proteins
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23C 19/05 - Treating milk before coagulationSeparating whey from curd

Abstract

The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 - 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated skim milk, UF milk or MCI obtainable by the process of the invention, and to a liquid heat-sterilized enteral nutritional composition comprising 2.0 - 3.0 kcal/ml wherein 16 - 35 en % is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 - 18 g/100 ml protein, preferably 12 - 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 - 80 mg/100kcal, preferably at least 30 - 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 - 80 mg/100kcal.

IPC Classes  ?

• A23C 7/04 - Removing unwanted substances from milk
• A23C 9/15 - Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
• A23J 1/20 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from milk, e.g. caseinObtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from whey
• A23J 3/10 - Casein
• A23J 3/32 - Working-up of proteins for foodstuffs by hydrolysis using chemical agents
• A23L 33/19 - Dairy proteins
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23C 19/05 - Treating milk before coagulationSeparating whey from curd

Abstract

The present invention concerns a powdered nutritional composition comprising dairy protein and plant-based protein with improved organoleptic properties and flowability, a dry-blending process for obtaining the nutritional composition and a method for providing nutrition to a subject comprising administering the nutritional composition. The nutritional compositions according to the invention have an improved flowability index and improved organoleptic properties.

IPC Classes  ?

• A23C 9/18 - Milk in dried and compressed or semi-solid form
• A23C 11/06 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk proteins
• A23J 3/16 - Vegetable proteins from soybean
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/185 - Vegetable proteins
• A23L 33/19 - Dairy proteins

Abstract

The present invention relates to a method of fortifying human nutrition with free amide containing amino acids, a method of providing infant nutrition to an infant of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy, and supplements or fortified infant formulas comprising free L-glutamine and/or free L-asparagine for use in the treatment or prevention of allergy in infants of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy.

IPC Classes  ?

• A61K 35/20 - MilkWheyColostrum
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61P 37/08 - Antiallergic agents

Abstract

A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening, connected to the collar by a first living hinge. The lid comprises a first lid portion and a second lid portion connected together by a second living hinge which traverses the top surface of the lid and is parallel to the first living hinge. The first lid portion covers the opening. The second lid portion comprises a mating element and the collar comprises a complementary mating element, being configured to engage together to latch the lid to the collar in the closed position of the lid, whereby latching and unlatching of the lid structure is provided by a pivotable motion of the second lid portion about the second living hinge.

IPC Classes  ?

• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 43/22 - Devices for holding in closed position, e.g. clips
• B65D 55/16 - Devices preventing loss of removable closure members

Abstract

A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.

IPC Classes  ?

• B21D 51/26 - Making hollow objects characterised by the use of the objects cans or tinsClosing cans or tins in a permanent manner
• B65D 8/00 - Containers having a curved cross-section formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
• B65D 17/00 - Rigid or semi-rigid containers specially constructed to be opened by cutting or piercing, or by tearing of frangible members or portions
• B21D 41/02 - Enlarging

Abstract

A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.

IPC Classes  ?

• B21D 51/26 - Making hollow objects characterised by the use of the objects cans or tinsClosing cans or tins in a permanent manner
• B21D 41/02 - Enlarging

Abstract

A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a first base diameter (D1) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the first base diameter can stack partially on the lid.

IPC Classes  ?

• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 43/02 - Removable lids or covers

Abstract

A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a base diameter (dr) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the same base diameter can stack partially on the lid.

IPC Classes  ?

• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 43/02 - Removable lids or covers

Abstract

The present invention concerns a powdered nutritional composition comprising intact protein and partially hydrolysed whey protein and a dry-blending process for obtaining the powdered nutritional composition.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23C 21/06 - Mixtures of whey with milk products or milk components
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/19 - Dairy proteins

Abstract

A method performed by an electronic device assessing a first nutritional composition, obtaining (201, 301, 401) first visual information of the first nutritional composition; determining (202) whether there is a phase separation of the first nutritional composition based on the first visual information; if it is determined that there is a phase separation, determining (203) properties of at least one layer of the phase separation of the first nutritional composition based on the first visual information.

IPC Classes  ?

• G01N 15/04 - Investigating sedimentation of particle suspensions
• A01J 1/00 - Devices or accessories for milking by hand
• G01N 21/84 - Systems specially adapted for particular applications
• A01J 11/16 - Homogenising milk
• A23C 9/00 - Milk preparationsMilk powder or milk powder preparations
• A23C 13/00 - CreamCream preparationsMaking thereof
• G01N 15/00 - Investigating characteristics of particlesInvestigating permeability, pore-volume or surface-area of porous materials
• G01N 33/06 - Determining fat content, e.g. by butyrometer

Abstract

A consortium of specific probiotic bacteria comprising Bifidobacterium bifidum and Bifidobacterium breve with specific carbohydrate degrading properties, specific human milk oligosaccharide and preferably also beta-galacto-oligosaccharides with a higher degree of polymerization, is particularly effective for improving intestinal microbiota resilience.

IPC Classes  ?

• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

Abstract

The invention pertains to a solid composition suitable for treating adult animals that suffer from brain-related disorders, brain-related decline or brain-related diseases, preferably suitable for treating adult animals that suffer from brain-related disorders, the composition containing (i) a uridine source, wherein the amount of the sum of all uridine sources, calculated on the basis of the weight of the molar equivalent of uridine monophosphate (UMP), is 0.3-15 g per 100 g dry weight of the composition, (ii) a polyunsaturated fatty acid, preferably an omega-3 polyunsaturated fatty acid, (iii) choline bitartrate, (iv) a buffering salt component, and (v) a milk protein source, wherein the milk protein source is a milk powder, and the buffering salt component containing at least one food approved salt, with a buffering capacity between pH 5-8, the buffering salt component preferably containing a mixture of food-approved salts, or a food-approved salt and its conjugated acid or base.

IPC Classes  ?

• A61K 31/7072 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
• A61K 31/14 - Quaternary ammonium compounds, e.g. edrophonium, choline
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 35/20 - MilkWheyColostrum

Abstract

The invention pertains to a liquid nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for improving whole body protein metabolism or whole body protein function, particularly for use in muscle decline, or for improving muscle function, in a human subject suffering from metabolic stress and/or starvation, wherein the human subject is preferably a human elderly subject of at least 50 years of age, wherein the composition comprises a protein fraction comprising (a) 15 to 35 weight % of casein; (b) 25 to 50 weight % of whey protein; (c) 10 to 30 weight % of soy protein; and (d) 10 to 30 weight % of pea protein; relative to the total protein in the protein fraction, wherein the sum of said proteins preferably equals 100 weight % of the protein fraction.

IPC Classes  ?

• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61P 3/02 - Nutrients, e.g. vitamins, minerals
• A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system

Abstract

Electronic device for estimating a height of a human, the electronic device comprising: a processor configured to: obtain an image including at least a part of a representation of the human and reference information; input the image to a first neural network and obtain as output from the first neural network first information, the first information related to a plurality of keypoints in the body of the human; input the image to a second neural network and obtain as output from the second neural network second information, the second information related to the reference information; and estimate the height of the human based on the first information and the second information; and an output unit configured to output the estimated height.

IPC Classes  ?

• G06T 7/60 - Analysis of geometric attributes
• G06T 7/70 - Determining position or orientation of objects or cameras

Abstract

The invention concerns a process for preparing an ultrafiltered whey protein hydrolysate comprising tolerogenic peptides wherein an emulsifier and/or a chaotropic agent is added before ultrafiltration. The invention further concerns the product obtainable by the process.

IPC Classes  ?

• A61K 35/20 - MilkWheyColostrum
• A23C 9/142 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
• A23C 21/02 - WheyWhey preparations containing, or treated with, microorganisms or enzymes
• A23C 21/08 - WheyWhey preparations containing other organic additives, e.g. vegetable or animal products
• A23J 3/08 - Dairy proteins
• A23J 3/34 - Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/19 - Dairy proteins
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 35/00 - Medicinal preparations containing materials or reaction products thereof with undetermined constitution
• A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• B01D 61/14 - UltrafiltrationMicrofiltration
• B01D 61/16 - Feed pretreatment
• C12P 21/06 - Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Abstract

Provided herein is an enteral ketogenic composition comprising (i) a lipid fraction comprising 45 to 65 g lipids, (ii) a carbohydrate fraction comprising 5 to 12 g digestible carbohydrates, and (iii) a protein fraction comprising 15 - 25 g of protein per 100g of the ketogenic composition, having a ketogenic weight ratio between 1.5:1 and 3.0:1 and therapeutic uses thereof.

IPC Classes  ?

• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/17 - Amino acids, peptides or proteins
• A23L 33/175 - Amino acids
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• A61K 31/14 - Quaternary ammonium compounds, e.g. edrophonium, choline
• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61K 31/201 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having one or two double bonds, e.g. oleic or linoleic acid
• A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
• A61K 31/717 - Celluloses
• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61K 31/733 - Fructosans, e.g. inulin
• A61K 33/00 - Medicinal preparations containing inorganic active ingredients
• A61K 38/00 - Medicinal preparations containing peptides
• A61K 38/01 - Hydrolysed proteinsDerivatives thereof

Abstract

The present invention concerns nutritional compositions for infants and young children that are high in oleic acid and low in palmitic acid and comprise galacto-oligosaccharides, in particular including beta1,3′-galactosyllactose. The nutritional compositions are particularly advantageous for improving intestinal barrier function.

IPC Classes  ?

• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/12 - Fatty acids or derivatives thereof
• A61K 31/201 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having one or two double bonds, e.g. oleic or linoleic acid
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

Goods & Services

Milk and milk products, excluding ice cream, ice milk and frozen yogurt; yogurt; milk substitutes; plant-based milk substitutes and milk products, excluding ice cream, ice milk and frozen yogurt, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits namely, plant-based milk substitutes and nut milk-based beverages; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar, namely cheese-based snack bars; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees Dietetic foods adapted for medical use; dietetic foods and beverages adapted for medical purposes; food for babies; food for patients and sick persons namely dietetic foods adapted for medical purposes; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits namely infant formula; nutritional products for medical purposes namely nutritionally fortified beverages for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods adapted for medical use, namely for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; nutritional supplement energy bars; dietary supplements for human beings

Abstract

The invention pertains to a nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for therapeutic use in improving whole body protein metabolism or whole body protein function, in a human subject, wherein the human subject is preferably an ageing human elderly subject of at least 40 years of age, wherein the composition comprises a protein fraction comprising 32-58 wt % pea protein, 30-56 wt % soy protein and 8-16 wt % free leucine, preferably a protein fraction comprising 36-54 wt % pea protein, 34-52 wt % soy protein and 10-14 wt % free leucine, and optionally up to 5 wt % of free branched chain amino acids other than leucine, based on all proteinaceous matter, wherein the composition is essentially free from animal protein.

IPC Classes  ?

• A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
• A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
• A61P 21/06 - Anabolic agents

Abstract

The present invention relates to a use of octenylsuccinyl anhydride substituted starch (OSA starch) for increasing the dry weight content and/or the fat content of a liquid composition that is subjected to a spray-drying step, and also to a process for preparing powders. The present invention enables the spray-drying of emulsions that contain a high amount of fat. The present invention also relates to the powder products obtainable by the process and nutritional products such as an infant milk powder, grow up milk, toddler milk or as a medical nutritional product that can be formulated therewith.

IPC Classes  ?

• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 29/219 - Chemically modified starchReaction or complexation products of starch with other chemicals
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/175 - Amino acids
• A23P 10/47 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added using additives, e.g. emulsifiers, wetting agents or dust-binding agents
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

The present invention relates to a powdered nutritional composition comprising (i) milk formula particles comprising lipid, protein, digestible carbohydrates, and (ii) human milk oligosaccharide (HMO) particles, wherein the nutritional composition is selected from an infant, follow-on formula and growing up milk, wherein said nutritional composition is not human milk and wherein the lipid in the milk formula particles is in the form of lipid globules, and a. the lipid globules have a mode diameter based on volume of at least 1 μm, and/or b. at least 40 vol.% of the lipid globules have a diameter of 2 to 12 μm and wherein the HMO particles comprise at least 2'fucosyllactose (2'FL). The invention also relates to a process to prepare the composition and uses thereof.

IPC Classes  ?

• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 2/39 - Dry compositions
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
• A61K 31/201 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having one or two double bonds, e.g. oleic or linoleic acid
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A61K 38/00 - Medicinal preparations containing peptides

Abstract

The present invention concerns nutritional compositions comprising a mixture of non-digestible oligosaccharides consisting of a combination of 5 specific human milk oligosaccharides, beta-galacto-oligosaccharides and long chain fructo-oligosaccharides (IcFOS). The nutritional compositions are of benefit for improving intestinal microbiota.

IPC Classes  ?

• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

Abstract

The present invention relates to nutritional compositions comprising non-digestible oligosaccharides and beta-casein comprising at least 75% by weight of a beta-casein variant having a proline at position 67 of the beta-casein amino acid sequence for use in improving gut microbiota of an infant or child, wherein improvement of gut microbiota encompasses increasing Lactobacillus levels. Advantageously, the composition further favors the increase of Bifidobacterium levels and inhibits the growth of opportunistic and/or pathogenic bacteria.

IPC Classes  ?

• A61K 35/745 - Bifidobacteria
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 35/00 - Medicinal preparations containing materials or reaction products thereof with undetermined constitution
• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans

Abstract

A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for improving the gut microbiota and reducing opportunistic pathogens in the gut of human infants.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Abstract

The present invention relates to the field of infant nutrition. Particularly, the present invention relates to infant formula comprising human milk oligosaccharides wherein the infant formula is specific for infants aged 0-36 months at different lactation stages. The invention also relates to lactation stage specific systems and methods of providing nutrition to an infant.

IPC Classes  ?

• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23C 9/20 - Dietetic milk products not covered by groups
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof

Abstract

The present invention relates to infant formula suitable for feeding infants who receive both infant formula and human breast milk (mixed milk fed infants).

IPC Classes  ?

• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof

Abstract

A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for increasing myelination in the brain of an infant who has delayed brain development or is at risk of having delayed brain development.

IPC Classes  ?

• A23C 9/152 - Milk preparationsMilk powder or milk powder preparations containing additives
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A61K 35/20 - MilkWheyColostrum
• A61P 25/00 - Drugs for disorders of the nervous system

Goods & Services

(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings. (2) Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees.

Goods & Services

(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings. (2) Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees.

Abstract

An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes.

IPC Classes  ?

• A61K 31/201 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having one or two double bonds, e.g. oleic or linoleic acid
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/688 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
• A61P 25/00 - Drugs for disorders of the nervous system

Goods & Services

Milk and milk products, excluding ice cream, ice milk and frozen yogurt; yogurt; milk substitutes; plant-based milk substitutes and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods excluding frozen yogurt; fruit purees Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely powdered milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes in the nature of nutritionally fortified beverages; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings

Abstract

The present invention relates to compositions comprising lutein, non-digestible carbohydrates and at least one of casein phosphopetides or 1,3-dioleoyl-2-palmitoylglycerol.

IPC Classes  ?

• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
• A23L 33/12 - Fatty acids or derivatives thereof
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
• A61K 31/07 - Retinol compounds, e.g. vitamin A
• A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61K 33/42 - PhosphorusCompounds thereof
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
• A61P 9/00 - Drugs for disorders of the cardiovascular system
• A61P 25/00 - Drugs for disorders of the nervous system

Goods & Services

Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely powdered milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes in the nature of nutritionally fortified beverages; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings

Abstract

The invention pertains to the use of therapeutically effective amounts of (a) (i) vitamin C and/or selenium and (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof; or (b) (i) vitamin C and/or selenium and (iii) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; or (c) a combination of (i), (ii) and (iii); wherein (a), (b) or (c) optionally further comprises vitamin E, in the manufacture of a product for therapeutically improving synaptic connectivity and/or therapeutically supporting memory and/or cognitive function in a human subject in need thereof.

IPC Classes  ?

• A61K 31/04 - Nitro compounds
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
• A61K 31/7068 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
• A61K 31/7072 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine

Goods & Services

Milk and milk products, excluding ice cream, ice milk and frozen yogurt; yogurt; milk substitutes; plant-based milk substitutes and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods excluding frozen yogurt; fruit purees Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely powdered milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes in the nature of nutritionally fortified beverages; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings

Abstract

The invention concerns formula for based on extensively hydrolysed protein and/or free amino acids for allergic infants that are thickened with a combination of xanthan gum and locust bean gum.

IPC Classes  ?

• A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
• A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• A61P 37/08 - Antiallergic agents
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

Abstract

The invention is in the field of thickened formulas for infants that suffer from regurgitation. In particular the infant formulas are thickened with a combination of xanthan gum and locust bean gum and comprise a mixture of specific nondigestible oligosaccharides.

IPC Classes  ?

• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
• A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• A61P 37/08 - Antiallergic agents

Abstract

The invention concerns formula for based on extensively hydrolysed protein and/or free amino acids for allergic infants that are thickened with a combination of xanthan gum and locust bean gum.

IPC Classes  ?

• A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
• A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
• A23L 33/175 - Amino acids
• A23L 33/18 - PeptidesProtein hydrolysates
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• A61P 37/08 - Antiallergic agents
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

Abstract

A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.

IPC Classes  ?

• B65D 3/22 - Rigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with double wallsRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls incorporating air-chambersRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls made of laminated material
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement

Abstract

A closure for an infant formula package is disclosed. The package may comprise a container having an access opening to an interior space, for receiving the infant formula. The closure is arranged for selectively closing the access opening and comprises a lid and a scoop holder located on an underside of the lid, wherein both the lid and the scoop holder are formed of card-based material.

IPC Classes  ?

• B65D 51/24 - Closures not otherwise provided for combined with auxiliary devices for non-closing purposes

Abstract

A closure for an infant formula package is disclosed. The package may comprise a container having an access opening to an interior space, for receiving the infant formula. The closure is arranged for selectively closing the access opening and comprises a lid and a scoop holder located on an underside of the lid to retain a scoop, wherein the scoop holder comprises an apertured plate having an apertured portion with an aperture therethrough to receive at least part of the scoop, and wherein both the lid and the scoop holder are formed of card-based material.

IPC Classes  ?

• B65D 51/24 - Closures not otherwise provided for combined with auxiliary devices for non-closing purposes

Abstract

A card-based package for powdered infant nutrition is described. The package comprises a container portion having an access opening to an interior space for receiving the powered infant nutrition and a closure arranged for selectively closing the access opening. The closure comprises a collar portion connected to the container portion, a lid portion pivotably connected to the collar portion and a locking arrangement for selectively engaging said lid portion to said collar portion. The container portion, the lid portion, the collar portion and the locking arrangement are all formed from card-based material. The locking arrangement comprises a first locking element arranged on the collar portion and a second locking element arranged on the lid portion wherein the first locking element and the second locking element are arranged to engage together to prevent the lid portion from being opened. One of the first or second locking elements is actionable by a user to disengage the other locking element and unlock the lid portion.

IPC Classes  ?

• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 6/00 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 51/20 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers

Abstract

A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.

IPC Classes  ?

• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 6/00 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 51/20 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers

Goods & Services

Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; dietic food adapted for invalids; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings. Provision of training and information about it, in the fields of preconception, pregnancy, birth, motherhood, baby care, parenting and nutrition, for parents, mothers and future parents, also via on-line connections; arranging, organizing and conducting educational seminars and conferences, including as provided by means of the internet, in the fields of baby nutrition, food and drink, including dietetic food and drink and food and drink adapted for medical use, as well as in the fields of health, parenting, personal hygiene, pregnancy, body and beauty care for babies, infants and pregnant, lactating and breast feeding women. Provision of advisory services and information in the field of health care, nutrition and on hygienic and beauty care for human beings, including advisory and information services in relation to issues about preconception, pregnancy, birth, motherhood, baby care and parenting, for parents, mothers and future parents, also via on-line connections; medical services; advisory, consultancy and information services, including as provided by means of the internet, in the fields of medicine, health care, baby nutrition, personal hygiene, body and beauty care for babies and infants, lactating and breast feeding women.

Abstract

A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.

IPC Classes  ?

• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 6/00 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 51/20 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers

Abstract

A card-based package for powdered infant nutrition is described. The package comprises a container portion having an access opening to an interior space for receiving the powered infant nutrition and a closure arranged for selectively closing the access opening. The closure comprises a collar portion connected to the container portion, a lid portion pivotably connected to the collar portion and a locking arrangement for selectively engaging said lid portion to said collar portion. The container portion, the lid portion, the collar portion and the locking arrangement are all formed from card-based material. The locking arrangement comprises a first locking element arranged on the collar portion and a second locking element arranged on the lid portion wherein the first locking element and the second locking element are arranged to engage together to prevent the lid portion from being opened. One of the first or second locking elements is actionable by a user to disengage the other locking element and unlock the lid portion.

IPC Classes  ?

• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement
• B65D 3/26 - Opening arrangements or devices incorporated in, or attached to, containers
• B65D 6/00 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
• B65D 21/02 - Containers specially shaped, or provided with fittings or attachments, to facilitate nesting, stacking, or joining together
• B65D 51/20 - Caps, lids, or covers co-operating with an inner closure arranged to be opened by piercing, cutting, or tearing
• B65D 77/24 - Inserts or accessories added or incorporated during filling of containers

Abstract

A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.

IPC Classes  ?

• B65D 3/22 - Rigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with double wallsRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls incorporating air-chambersRigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines with walls made of laminated material
• B65D 43/16 - Non-removable lids or covers hinged for upward or downward movement

Abstract

A process of preparing a shelf-stable liquid enteral nutritional composition, said process comprising the steps of providing an oil-in-water emulsion, sterilizing the emulsion by direct steam injection (DSI) to obtain a sterilized emulsion with a F0 value of at least 3 and subjecting the sterilized emulsion to high pressure homogenization.

IPC Classes  ?

• A23L 3/3409 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
• A23L 5/30 - Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
• A23C 9/20 - Dietetic milk products not covered by groups
• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23C 11/00 - Milk substitutes, e.g. coffee whitener compositions

Abstract

A nutritional composition comprising sn-2 palmitic acid and A2 beta-casein for use in improving the gut microbiota in a human subject.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

Abstract

A nutritional composition comprising sn-2 palmitic acid and lactoferrin for use in improving the gut microbiota in a human subject.

IPC Classes  ?

• A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
• A23L 33/115 - Fatty acids or derivatives thereofFats or oils
• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23L 33/19 - Dairy proteins
• A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

Abstract

A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.

IPC Classes  ?

• G06V 10/10 - Image acquisition
• G06V 10/40 - Extraction of image or video features

Abstract

A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.

IPC Classes  ?

• A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates